ROS-responsive microneedle patch for targeted acne treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for acne, such as topical antibiotic creams and oral antibiotics, face limitations in drug transport to pilosebaceous units, leading to reduced efficacy and side effects like intestinal damage and teratogenic effects, necessitating improved delivery methods that provide targeted, sustained release of therapeutic agents.
Innovation Solution
Development of bioresponsive compositions comprising biodegradable polymers and crosslinked hydrophilic polymers with inflammation- or ROS-responsive linkages, embedded with antibiotics like clindamycin, delivered through microneedle arrays or skin patches, which release the drug in response to inflammatory conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If topical antibiotic creams are used, then acne treatment is applied locally, but drug transport to pilosebaceous units is limited resulting in reduced efficacy
Solution Approach 1:
The treatment system is segmented into multiple functional components: microneedles for physical penetration, bioresponsive polymers for targeted release, and absorbent materials for sebum removal. This segmentation allows each component to address a specific barrier in drug delivery to the pilosebaceous unit.
Solution Approach 2:
The patent introduces an intermediary delivery system comprising microneedles and bioresponsive polymer matrices that facilitate drug transport from the application site to the pilosebaceous unit. The microneedles act as conduits for penetrating the stratum corneum, while the polymer matrix serves as a controlled-release intermediary.
2Reliability
If oral antibiotics are administered, then systemic acne treatment is achieved, but undesirable side effects occur including intestinal microflora damage and teratogenic effects
Solution Approach 1:
The treatment system implements local quality by concentrating the antibiotic delivery specifically at the acne-affected sites through microneedle penetration and bioresponsive release mechanisms. This localized approach eliminates the need for systemic oral administration, thereby maintaining treatment efficacy while avoiding widespread side effects.
Solution Approach 2:
The patent extracts the harmful systemic side effects by removing the oral administration route entirely. Instead, the antibiotic is delivered locally through microneedles directly to the pilosebaceous units, separating the therapeutic benefit from the harmful systemic effects associated with oral antibiotics.
3Ease of operation
If conventional topical treatments are used, then simple application is maintained, but sustained release of effective amounts of therapeutic agent is not achieved
Solution Approach 1:
The bioresponsive polymer matrix enables continuous and sustained release of the antibiotic over an extended period. The polymer's bioresponsive characteristics allow it to maintain drug release functionality throughout the treatment duration, ensuring continuous therapeutic action without requiring frequent reapplication.
Solution Approach 2:
The patent employs composite materials combining microneedles, bioresponsive polymers, and absorbent additives in a single integrated patch. This composite structure simultaneously provides mechanical penetration, controlled sustained release, and sebum absorption, maintaining simple application while achieving prolonged therapeutic action.
4Reliability
If targeted delivery to pilosebaceous unit is improved, then treatment efficacy increases, but device complexity increases
Solution Approach 1:
The patent merges multiple functions into a single integrated microneedle patch device. The microneedles, bioresponsive polymer matrix, and absorbent materials are combined in one unit that performs penetration, controlled release, and sebum absorption simultaneously. This consolidation achieves targeted delivery efficacy while minimizing the complexity that would arise from multiple separate devices.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bioresponsive delivery system enhances antibiotic release and penetration into affected skin areas, improving acne treatment efficacy while minimizing side effects by targeting specific inflammatory conditions, such as increased ROS concentrations.
Implementation Method 1
a crosslinked hydrophilic polymer with a plurality of ROS-responsive linkages... The bioresponsive linker can be responsive to inflammation and/or reactive oxygen species (ROS)
Implementation Method 2
a biodegradable polymer, such as a polyester... The composition can comprise a biodegradable polymer
Implementation Method 3
The composition can further comprise an absorbent material... compositions comprising absorbent materials
Data Source
AI summary
A composition comprising a bioresponsive (e.g., reactive oxygen species (ROS)-responsive), antibiotic- and/or absorbent-loaded polymeric network is described. In some cases, the composition can release the antibiotic loaded therein in response to ROS or another stimulus related to inflammation. Microneedles, microneedle arrays, and skin patches comprising the composition are also described, as well as methods of treating acne or other inflammatory/infectious skin conditions.